IGFBP4 and colonic neoplasm: In this study we assessed the preventive role of IGFBP-4 in colon cancer in the form of gene therapy in vivo and found that IGFBP-4 did not prevent the establishment of cancer in HT-29 colon cancer model but it increased the cell death, apoptosis and decreased tumour proliferation.